Biogen lists 10 executives, led by Christopher A. Viehbacher, President, CEO & Director (age 64). Robin C. Kramer is the company's Executive VP & CFO (age 59).
In fiscal year 2025 the highest-paid executive was Christopher A. Viehbacher, President, CEO & Director, with total pay of $5.28 million. The 4 executives with reported pay received $10.92 million in all.
The average age of the executives with a known age is 55; the youngest is 48 and the oldest 64.
Titles, ages and pay from company filings; pay for fiscal year 2025.

President, CEO & Director
Executive VP & CFO
Executive VP and Head of Pharmaceutical Operations & Technology
Executive VP & Head of Development
VP, Chief Accounting Officer & Global Corporate Controller
Chief Information Officer
Head of Investor Relations
Chief Legal Officer
Chief Communication Officer & Head of Corporate Affairs
Executive VP & Head of Corporate Development
| Executive | Title | Age | Total pay |
|---|---|---|---|
| Christopher A. Viehbacher | President, CEO & Director | 64 | $5.28 million |
| Nicole Murphy | Executive VP and Head of Pharmaceutical Operations & Technology | 52 | $2.01 million |
| Priya Singhal M.D., M.P.H. | Executive VP & Head of Development | 57 | $2.01 million |
| Robin C. Kramer | Executive VP & CFO | 59 | $1.63 million |
Total pay as reported for the fiscal year; it can include salary, bonus and stock awards.
Christopher A. Viehbacher (President, CEO & Director), age 64; total pay in fiscal year 2025 was $5.28 million.
Robin C. Kramer (Executive VP & CFO), age 59.
Christopher A. Viehbacher, President, CEO & Director, with total pay of $5.28 million in fiscal year 2025.
Christopher A. Viehbacher (President, CEO & Director), Robin C. Kramer (Executive VP & CFO), Nicole Murphy (Executive VP and Head of Pharmaceutical Operations & Technology), Priya Singhal M.D., M.P.H. (Executive VP & Head of Development) and Sean Godbout (VP, Chief Accounting Officer & Global Corporate Controller), and 5 more.